Admission Leukocytosis Is Not Associated with Early Response to Tissue Plasminogen Activator in Patients with Acute Ischemic Stroke

被引：0
|
作者：
Gillette, Michael [1 ]
Siegler, James [1 ]
Kumar, Andre [1 ]
Boehme, Amelia [2 ]
Martin-Schild, Sheryl [1 ]
Albright, Karen [3 ]
机构：
[1] Tulane Univ Hosp, Dept Neurol, Stroke Program, New Orleans, LA USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Neurol, Sch Med, Birmingham, AL 35294 USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P02198
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation
    Lawson, T. R.
    Brown, I. E.
    Westerkam, D. L.
    Blackhurst, D. W.
    Sternberg, S.
    Leacock, R.
    Nathaniel, T. I.
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2015, 33 (03) : 301 - 308
  • [42] Relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator
    Wada, Tomoki
    Yasunaga, Hideo
    Inokuchi, Ryota
    Horiguchi, Hiromasa
    Fushimi, Kiyohide
    Matsubara, Takehiro
    Nakajima, Susumu
    Yahagi, Naoki
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (01) : 73 - 78
  • [43] Is acute stress and plasminogen activator inhibitor polymorphism associated with acute ischemic stroke?
    Kozak, Hasan Huseyin
    Uca, Ali Ulvi
    Altas, Mustafa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 143 : 159 - 160
  • [44] Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients
    Chou, Claudia
    Bourekas, Eric C.
    Slivka, Andrew
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (07): : 1823 - 1827
  • [45] Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator
    Chen, Jie
    Zhang, Fu-Liang
    Lv, Shan
    Jin, Hang
    Luo, Yun
    Qu, Yang
    Guo, Zhen-Ni
    Yang, Yi
    CURRENT NEUROVASCULAR RESEARCH, 2021, 17 (05) : 660 - 666
  • [46] Carotid Artery Perivascular Adipose Tissue Density and Response to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke
    Gencer, Elif Sarionder
    Yilmaz, Ezgi
    Arsava, Ethem Murat
    Gocmen, Rahsan
    Topcuoglu, Mehmet Akif
    ANGIOLOGY, 2024, 75 (05) : 472 - 479
  • [47] Factors Affecting "Golden Hour" Administration of Tissue Plasminogen Activator for Patients With Acute Ischemic Stroke
    Akbar, A.
    Rafique, Z.
    Hussein, H.
    Sergot, P.
    ANNALS OF EMERGENCY MEDICINE, 2018, 72 (04) : S135 - S136
  • [48] The Emerging Role of Recombinant Tissue Plasminogen Activator in Improving Neuroplasticity in Patients With Acute Ischemic Stroke
    Soliman, Rasha
    Mamdoh, Hend
    Hussein, Mona
    Rashed, Laila
    NEUROLOGY, 2019, 92 (15)
  • [49] Tissue Plasminogen Activator Overdose in Acute Ischemic Stroke Patients Linked to Poorer Functional Outcomes
    Sahlas, Demetrios J.
    Gould, Linda
    Swartz, Richard H.
    Mohammed, Naufal
    McNicoll-Whiteman, Rhonda
    Naufal, Fahd
    Oczkowski, Wieslaw
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (01): : 155 - 159
  • [50] Simultaneous Administration of Recombinant Tissue Plasminogen Activator and Edaravone in Acute Cerebral Ischemic Stroke Patients
    Takenaka, Katsunobu
    Kato, Masayasu
    Yamauti, Keita
    Hayashi, Katsuhiko
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (10): : 2748 - 2752
12345